LRPAP1 and early-onset autosomal dominant Alzheimer disease: Having found that LRPAP1 inhibits microglial phagocytosis of synaptosomes and cells, we next tested whether LRPAP1 affected Aβ uptake by BV-2 or CHME3 microglia, an activity relevant to Alzheimer’s disease (40).